Specialist physician perspectives on non-medical switching of prescription medications-Reference-Cited by-同舟云学术

Specialist physician perspectives on non-medical switching of prescription medications

Published:2020-01-01 Issue:1 Volume:8 Page:1738637
ISSN:2001-6689
Container-title:Journal of Market Access & Health Policy
language:en
Short-container-title:Journal of Market Access & Health Policy

Author:

Costa Olivia S.¹²,Salam Tabassum³,Duhig Amy⁴,Patel Aarti A.⁵,Cameron Ann⁴,Voelker Jennifer⁵,Bookhart Brahim⁵,Coleman Craig I.¹²

Affiliation:

1. School of Pharmacy, University of Connecticut, Storrs, CT, USA

2. Evidence-Based Practice Center, Hartford Hospital, Hartford, CT, USA

3. Medical Education, American College of Physicians, Philadelphia, PA, USA

4. Consulting Services, Xcenda, Palm Harbor, FL, USA

5. Real World Value and Evidence, Janssen Scientific Affairs, LLC, Titusville, NJ, PA, USA

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/20016689.2020.1738637

Reference14 articles.

1. The non-medical switching of prescription medications

2. American Medical Association. H-125.991 Drug formularies and therapeutic interchange. Available at: https://policysearch.ama-assn.org/policyfinder/detail/Drug%20Formularies%20and%20Therapeutic%20Interchange%20H-125.991?uri=%2FAMADoc%2FHOD.xml-0-227.xml. [cited 2019 Nov 4

3. Prior Authorization and Utilization Management Reform Principles. American Medical Association. 2017. [cited 2019 Nov 4]. Available from: https://www.ama-assn.org/sites/default/files/media-browser/principles-with-signatory-page-for-slsc.pdf

4. Impact of non-medical switching on clinical and economic outcomes, resource utilization and medication-taking behavior: a systematic literature review

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-Medical Switching or Discontinuation Patterns among Patients with Non-Valvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United States: A Claims-Based Analysis;Journal of Market Access & Health Policy;2024-09-02

2. The economic impact of suboptimal treatment and treatment switch among patients with Crohn’s disease treated with a first-line biologic – A US retrospective claims database study;Journal of Medical Economics;2024-07-16

3. Interleukin 6 receptor inhibitors in the treatment of rheumatoid arthritis during the COVID-19 pandemic, Moscow experience;Modern Rheumatology Journal;2022-12-18

4. Perspectives on Nonmedical Switching and the COVID-19 Pandemic: A Narrative Review;The American Journal of Managed Care;2022-09-26

5. Non-medical switching in dermatology: cost-conscious policy or an affront to patient safety?;Journal of Dermatological Treatment;2022-08-18